Results 191 to 200 of about 21,976 (228)
Some of the next articles are maybe not open access.
Blood, 2023
Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive disease of malignant CD4+ T cells that develops in human T-lymphotropic virus-1 (HTLV-1) carriers. Patients diagnosed with ATLL have the worst survival among all peripheral T-cell lymphomas.
B. Hilda Ye +10 more
openaire +1 more source
Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive disease of malignant CD4+ T cells that develops in human T-lymphotropic virus-1 (HTLV-1) carriers. Patients diagnosed with ATLL have the worst survival among all peripheral T-cell lymphomas.
B. Hilda Ye +10 more
openaire +1 more source
Novel roles of the
The CCR4–NOT complex is a multi‐subunit protein complex evolutionarily conserved across eukaryotes which regulates several aspects of gene expression. A fascinating model is emerging in which this complex acts as a regulation platform, controlling gene products ‘from birth to death’ through the coordination of different cellular machineries involved in
Clément, Chapat, Laura, Corbo
openaire +2 more sources
Optimization of CCR4 Antagonists: Side‐Chain Exploration.
ChemInform, 2006AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Ashok V, Purandare +8 more
openaire +2 more sources
CCR4 Expression in Hodgkin Lymphoma
Blood, 2011Abstract Abstract 2626 In Hodgkin lymphoma (HL) a minority (<1%) of tumor cells is found in a reactive background. The tumor cells shape their environment by the production of several chemokines and cytokines. Production of the chemokine TARC will lead to the attraction of Th2 and Treg cells specifically to involved ...
Lydia Visser +4 more
openaire +1 more source
Structure and assembly of the NOT module of the human CCR4–NOT complex
Nature Structural & Molecular Biology, 2013The CCR4-NOT deadenylase complex is a master regulator of translation and mRNA stability. Its NOT module orchestrates recruitment of the catalytic subunits to target mRNAs. We report the crystal structure of the human NOT module formed by the CNOT1, CNOT2 and CNOT3 C-terminal (-C) regions.
Andreas Boland +7 more
openaire +3 more sources
The Ccr4-Not Complex: Architecture and Structural Insights
2017The Ccr4-Not complex is an essential multi-subunit protein complex that plays a fundamental role in eukaryotic mRNA metabolism and has a multitude of different roles that impact eukaryotic gene expression . It has a conserved core of three Not proteins, the Ccr4 protein, and two Ccr4 associated factors, Caf1 and Caf40.
Collart, Martine, Panasenko, Olesya
openaire +4 more sources
Discovery and SAR of Trisubstituted Thiazolidinones as CCR4 Antagonists.
ChemInform, 2004AbstractFor Abstract see ChemInform Abstract in Full Text.
Shelley, Allen +8 more
openaire +2 more sources
Optimization of 2-aminothiazole derivatives as CCR4 antagonists
Bioorganic & Medicinal Chemistry Letters, 2006A series of 2-aminothiazole-derived antagonists of the CCR4 receptor has been synthesized and their affinity for the receptor evaluated using a [(125)I]TARC (CCL17) displacement assay. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent, orally bioavailable antagonists.
Xuemei, Wang +13 more
openaire +2 more sources
The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis
Journal of Neuroimmunology, 2013Chemokine receptors (CCRs) play important roles in the pathogenesis of immune-mediated diseases, as well as in normal immune response. We examined the role of CCR6 and CCR4 in experimental autoimmune encephalomyelitis (EAE) by using CCR6(-/-)CCR4(-/-) double knockout (DKO) and single knockout mice.
Kota, Moriguchi +4 more
openaire +2 more sources
2000
CCR4 receptor antagonists are used for treatment and/or prevention of sepsis and/or septic shock. The antagonists of this invention typically are selected among several classes but preferably are anti-CCR4 antibodies.
APPLIED RESEARCH SYSTEMS +2 more
openaire +1 more source
CCR4 receptor antagonists are used for treatment and/or prevention of sepsis and/or septic shock. The antagonists of this invention typically are selected among several classes but preferably are anti-CCR4 antibodies.
APPLIED RESEARCH SYSTEMS +2 more
openaire +1 more source

